DrugCard
DrugCard is an AI tool for local literature screening in the pharmaceutical industry, providing transparency, scalability, and cost-effectiveness.
December 29th, 2024
About DrugCard
DrugCard is an AI tool designed to streamline drug safety routines and ensure compliance with regulatory demands. It offers continuous screening, transparency, scalability, and cost-effectiveness, making it an efficient choice for pharma companies. With global coverage and a high accuracy rate, DrugCard empowers various pharmaceutical users to manage more projects, mitigate risks, optimize time, and expand operations with confidence.
Key Features
- Continuous Screening: Keep up-to-date with the latest local literature in pharmaceutical markets through regular, automated screening.
- Transparency: Monitor and track the screening process for accuracy, completeness, and holistic coverage.
- Scalability: Expand pharmaceutical operations globally with support for new markets, multiple languages, and suppliers.
- Cost-Effective: Achieve cost savings by avoiding heavy capital investments, making DrugCard an efficient choice for pharma companies.
- Global Coverage: Access medical journals from over 35 countries in more than 100 languages, ensuring comprehensive screening.
- User-Friendly: Tailored for various pharmaceutical users, including Contract Research Organizations (CROs), Marketing Authorization Holders (MAHs), and freelancers.
- Efficiency: Manage more projects and improve screening results with DrugCard, saving valuable time and resources.
- Risk Mitigation: Perform in-house screening to mitigate compliance and reputation risks for MAHs.
- Cost Savings: Freelancers can optimize their time by automating literature screening and focusing on value-added tasks.
- Global Expansion: Easily expand pharmaceutical operations into new markets with DrugCard's scalability and global coverage.
- Reliability: Trust in DrugCard's high accuracy rate for scanned PDF screening.
Use Cases
- Pharmaceutical companies can use DrugCard to streamline their drug safety routines and ensure compliance with regulatory demands.
- Contract Research Organizations (CROs) can benefit from DrugCard's user-friendly interface and high accuracy rate for scanned PDF screening to manage more projects efficiently.
- Marketing Authorization Holders (MAHs) can perform in-house screening to mitigate compliance and reputation risks.
- Freelancers can optimize their time by automating literature screening with DrugCard and focusing on value-added tasks.
- Any pharmaceutical user can expand their operations globally with DrugCard's support for new markets, multiple languages, and suppliers.
Loading reviews...
